Literature DB >> 32509225

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity.

Zahra Delavarian1, Pouran Layegh2, Atessa Pakfetrat1, Nazila Zarghi3, Mahboubeh Khorashadizadeh4, Ala Ghazi1.   

Abstract

BACKGROUND: Pemphigus is an autoimmune blistering disease of the skin and mucous membranes caused by autoantibodies against desmoglein 1 (Dsg1) and desmoglein 3 (Dsg3). Pemphigus vulgaris (PV) is the most common form of pemphigus. The aim of this study was to assess the correlation between the levels of anti-desmoglein 1 and 3 autoantibodies and the severity of PV disease.
MATERIAL AND METHODS: Nineteen newly diagnosed patients with pemphigus vulgaris were enrolled in this study. The titers of Dsg in subjects by using enzyme-linked immunosorbent assay (ELISA) were done at diagnosis time-point, 4th and 8th weeks after the initiation of treatment, and the correlation of antibodies with the oral and skin disease severity was evaluated.
RESULTS: The severity of cutaneous lesions was significantly correlated with anti-Dsg1 titer in all visits and the severity of mucosal lesions was correlated with the titer of Dsg3 in the third visit (<0.001, 0.001, 0.016 and 0.015 P value, respectively).
CONCLUSIONS: Anti-Dsg-1 autoantibodies titers seem to be more useful in showing the extent of the disease and activity in pemphigus with mucocutaneous lesions. Key words:Pemphigus vulgaris, Desmoglein (Dsg), Enzyme-linked immunosorbent assay (ELISA). Copyright:
© 2020 Medicina Oral S.L.

Entities:  

Year:  2020        PMID: 32509225      PMCID: PMC7263783          DOI: 10.4317/jced.56289

Source DB:  PubMed          Journal:  J Clin Exp Dent        ISSN: 1989-5488


  22 in total

Review 1.  Pemphigus.

Authors:  Jean-Claude Bystryn; Jennifer L Rudolph
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

2.  Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients.

Authors:  Evangelia Z Michailidou; Maria A Belazi; Anastasios K Markopoulos; Michael I Tsatsos; Olga N Mourellou; Demetrios Z Antoniades
Journal:  Int J Dermatol       Date:  2007-04       Impact factor: 2.736

3.  Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.

Authors:  D De; G Khullar; S Handa; N Joshi; B Saikia; R W Minz
Journal:  Clin Exp Dermatol       Date:  2017-05-22       Impact factor: 3.470

Review 4.  [Pemphigus. Loss of desmosomal cell-cell contact].

Authors:  E Schmidt; E B Bröcker; D Zillikens
Journal:  Hautarzt       Date:  2000-05       Impact factor: 0.751

5.  The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.

Authors:  K E Harman; P T Seed; M J Gratian; B S Bhogal; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

6.  Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.

Authors:  Z Hallaji; H Mortazavi; V Lajevardi; B Tamizifar; A AmirZargar; M Daneshpazhooh; C Chams-Davatchi
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-08-26       Impact factor: 6.166

7.  ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

Authors:  Claire Abasq; Hugo Mouquet; Danièle Gilbert; François Tron; Vanessa Grassi; Philippe Musette; Pascal Joly
Journal:  Arch Dermatol       Date:  2009-05

8.  Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test.

Authors:  Anh Tran Thi Van; Thuong Van Nguyen; Sau Nguyen Huu; Lan Pham Thi; Phuong Pham Thi Minh; NghiDinh Huu; Van Tran Cam; My Le Huyen; Minh Vu Nguyet; Khang Tran Hau; Marco Gandolfi; Francesca Satolli; Claudio Feliciani; Michael Tirant; Aleksandra Vojvodic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-01-22

9.  Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.

Authors:  Anna Belloni-Fortina; Diana Faggion; Barbara Pigozzi; Andrea Peserico; Matteo Bordignon; Vincenzo Baldo; Mauro Alaibac
Journal:  Clin Dev Immunol       Date:  2009-12-10

10.  Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity.

Authors:  Naiyu Lin; Qingxiu Liu; Menglei Wang; Qian Wang; Kang Zeng
Journal:  PeerJ       Date:  2018-08-03       Impact factor: 2.984

View more
  1 in total

Review 1.  Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases.

Authors:  Ilana Heckler; Michael Hong; Animesh Amart Sinha; Iswariya Venkataraman
Journal:  Dermatol Pract Concept       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.